The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma

Advances in Medical Sciences

Volumn 57, Issue 1, 2012, Pages 124-135

  Starska, K ^a   Forma, E ^b   Brys M ^b   Glowacka E ^c   Lewy Trenda, I ^a   Lukomski M ^a   Krajewska, W M ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

laryngeal carcinoma; proinflammatory cytokines; toll like receptor (TLR) pathway molecules; tumor front grading (TFG)

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CARTILAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

EID: 84865179468     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-011-0058-3     Document Type: Article

References (25)

1. Carracedo DG, Astudillo A, Rodrigo JP, Suarez C,Gonzalez MV. Skp2, p27kip1 and EGFR assessment in headand neck squamous cell carcinoma: prognostic implications.Oncol Rep. 2008 Sep;20(3):589-95
2. Swellam M, El-Arab LR, Adly A. Prognosticvalue of cell-cycle regulators and cellular biomarkers inlaryngeal squamous cell carcinoma. Clin Biochem. 2008Sep;41(13):1059-66
3. Kumar B, Cordell KG, D'Silva N, Prince ME, AdamsME, Fisher SG, Wolf GT, Carey TE, Bradford CR. Expressionof p53 and Bcl-xL as predictive markers for larynx preservationin advanced laryngeal cancer. Arch Otolaryngol Head NeckSurg. 2008 Apr;134(4):363-9
4. Starska K, Brys M, Forma E, Glowacka E, Lewy-Trenda I, Stasikowska O, Krajewska WM, Lukomski M.Impact of EGFR immunoexpression on STAT3 activation andassociation with proinflammatory/regulatory cytokine patternin lryngeal squamous cell carcinoma. Oncol Rep. 2009Feb;21(2):539-48
5. Ioachim E, Peschos D, Goussia A, Mittari E,Charalabopoulos K, Michael M, Salmas M, VougiouklakisT, Assimakopoulos D, Agnantis NJ. Expression patterns ofcyclins D1, E in laryngeal epithelial lesions: correlation withother cell cycle regulators (p53, pRb, Ki-67 and PCNA) andclinicopathological features. J Exp Clin Cancer Res. 2004Jun;23(2):277-83
6. Micozkadioǧlu D, Unal M, Pata YS, Baştürk M, CinelL. Prognostic value of expression of p53, proliferating cellnuclear antigen, and c-erbB-2 in laryngeal carcinoma. MedSci Monit. 2008 Jun;14(6):CR299-304
7. Pries R, Wulff S, Wollenberg B. Toll-like receptormodulation in head and neck cancer. Crit Rev Immunol.2008;28(3):201-13
8. Pries R, Hogrefe L, Xie L, Frenzel H, Brocks C,Ditz C, Wollenberg B. Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neckcancer. Int J Mol Med. 2008 Feb;21(2):209-15
9. Cannon TY, Guttridge D, Dahlman J, George JR, LaiV, Shores C, Buzková P, Couch ME. The effect of altered Tolllikereceptor 4 signaling on cancer cachexia. Arch OtolaryngolHead Neck Surg. 2007 Dec;133(12):1263-9
10. Frenzel H, Hoffmann B, Brocks C, Schlenke P, PriesR, Wollenberg B. Toll-like receptor interference in myeloiddendritic cells through head and neck cancer. Anticancer Res.2006 Nov-Dec;26(6B):4409-13
11. Szczepański M, Stelmachowska M, Stryczyński L,Golusiński W, Samara H, Mozer-Lisewska I, Zeromski J.Assessment of expression of toll-like receptors 2, 3 and 4in laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2007May;264(5):525-30
12. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH,Mayer L, Unkeless JC, Xiong H. Toll-like receptors on tumorcells facilitate evasion of immune surveillance. Cancer Res.2005 Jun 15;65(12):5009-14
13. Takeda K, Akira S. Toll-like receptors in innateimmunity. Int Immunol. 2005 Jan;17(1):1-14
14. Akira S, Takeda K. Toll-like receptor signalling. NatRev Immunol. 2004 Jul;4(7):499-511
15. Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, ChoiS. Toll-like receptor signal transduction. Exp Mol Med. 2007Aug 31;39(4):421-38
16. Bose A, Chakraborty T, Chakraborty K, Pal S, Baral R. Dysregulation in immune functions is reflected in tumor cellcytotoxicity by peripheral blood mononuclear cells from headand neck squamous cell carcinoma patients. Cancer Immun.2008 Jun 12;8:10
17. Walsh JE, Lathers DM, Chi AC, Gillespie MB, DayTA, Young MR. Mechanisms of tumor growth and metastasisin head and neck squamous cell carcinoma. Curr Treat OptionsOncol. 2007 Jun;8(3):227-38
18. Schafer ZT, Brugge JS. IL-6 involvement in epithelialcancers. J Clin Invest. 2007 Dec;117(12):3660-3
19. O'Sullivan B, Shah J. New TNM staging criteria forhead and neck tumors. Semin Surg Oncol. 2003;21(1):30-42
20. Starska K, Forma E, Lewy-Trenda I, StasikowskaO, Bryś M, Krajewska WM, Ukomski M. The expressionof SOCS1 and TLR4-NFkappaB pathway molecules inneoplastic cells as potential biomarker for the aggressivetumor phenotype in laryngeal carcinoma. Folia HistochemCytobiol. 2009 Jan;47(3):401-10
21. Starska K, Głowacka E, Lewy-Trenda I, StasikowskaO, Ukomski M. EGFR immunoexpression and peripheralblood cytokine secretion as potential biomarkers of tumorbehavior in laryngeal squamous cell carcinoma. Med SciMonit. 2009 Oct;15(10):CR518-527
22. Ma A, Turer E. E2 enzymes: expanding the 'ubi-verse'of immune signaling. Nat Immunol. 2006 Sep;7(9):903-4
23. Uematsu S, Akira S. Toll-like receptors and Type Iinterferons. J Biol Chem. 2007 May 25;282(21):15319-23
24. Riedel F, Zaiss I, Herzog D, Götte K, Naim R, HörmannK. Serum levels of interleukin-6 in patients with primary headand neck squamous cell carcinoma. Anticancer Res. 2005 Jul-Aug;25(4):2761-5
25. Sparano A, Lathers DM, Achille N, PetruzzelliGJ, Young MR. Modulation of Th1 and Th2 cytokineprofiles and their association with advanced head and necksquamous cell carcinoma. Otolaryngol Head Neck Surg. 2004Nov;131(5):573-6. 135